US2719844A - Method of producing nucleosides by chemical processing - Google Patents

Method of producing nucleosides by chemical processing Download PDF

Info

Publication number
US2719844A
US2719844A US315183A US31518352A US2719844A US 2719844 A US2719844 A US 2719844A US 315183 A US315183 A US 315183A US 31518352 A US31518352 A US 31518352A US 2719844 A US2719844 A US 2719844A
Authority
US
United States
Prior art keywords
nucleic acid
solution
molar
nucleosides
buffering
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US315183A
Inventor
Dimroth Karl
Kurt Georg V Holle
Hamm Reiner
Jaenicke Lothar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US315183A priority Critical patent/US2719844A/en
Application granted granted Critical
Publication of US2719844A publication Critical patent/US2719844A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives

Definitions

  • the production of nucleosides by hydrolytic cleaving of nucleic acid can be carried through by a 3-4 hours treatment with ammonia at a heat of 175-180 C. In this case a mixture of the purineand pyrimidine-nucleosides is obtained.
  • the disadvantage of this process consists in realizing a bad yield and in being forced to work with *pressure vessels. If treated under more moderate conditions, e. g. at 115 C., the nucleic acid is only degraded into the mono-nucleotides.
  • the hydrolysis of the nucleic acid can also be done without employing the usual inorganic and organic bases if using a neutral aqueous solution at a pH value of 6.5-8, preferably 7- 7.5, this pH value being kept constant by buffering in order to re-rendering inactive the phosphoric acid nascent at the cleaving-process.
  • a neutral aqueous solution at a pH value of 6.5-8, preferably 7- 7.5, this pH value being kept constant by buffering in order to re-rendering inactive the phosphoric acid nascent at the cleaving-process.
  • all buffering compounds may be used that are capable to maintain the mentioned pH-value.
  • buifering compounds are materials, which in an aqueous solution at a given concentration show a determined pH-value and tend to maintain its pH-value even then if acid or basic material is added.
  • Inorganic or organic buffering compounds may be employed.
  • the phosphoric acid, formed by the hydrolytic cleavage of nucleic acid is buffered and consequently prevented from a further cleavage of the nucleosides formed. Therefore the desired hydrolytic cleaving of the nucleic acid is not specifically due to the cleaving-agent but to means that maintain a determined range of pH.
  • Example 1 110 g. of unrefined nucleic acid are brought to suspension in 200 ml. of water, its pH being adjusted to 7 with soda-lye, and are diluted'with 10-20 times the quantity of buffer-solution favoring a pH-value of 7 (sodium citrate and soda-lye) which is followed by 9- 10 days boiling at the reflux-cooler. Then the guanosine precipitate is filtered 01f. Yield: 10 g. Hereafter the adenosine is separated directly or as a compound of ditficult solubility.
  • Example 2 g. of unrefined nucleic acid with 70-75% pure nucleic acid content are brought to suspension in 200 ml. water, its pH being adjusted to 7.0 with soda-lye, and diluted with 1-2 liters of a buffering molar alkaline phosphate solution according to Stirensen, containing 70 parts of secondary alkaline phosphate and 30 parts of primary alkaline phosphate.
  • a buffering molar alkaline phosphate solution according to Stirensen containing 70 parts of secondary alkaline phosphate and 30 parts of primary alkaline phosphate.
  • the nucleic acid is cleaved.
  • the guanosine precipitate is separated and the adenosine directly isolated from the hydrolytic solution or as a compound of difficult solubility. Yields: 12.2 g. guanosine and 10.5 g. adenosine.
  • Example 3 100 g. of unrefined nucleic acid with 7075% pure nucleic acid content are brought to suspension in 200 ml. water, its pH being adjusted to 7.0 with soda-lye, and diluted with l-2 liters of a buffering molar alkaline phosphate solution according to Clark and Lubs, consisting of 296 ml. normal solution of sodium hydrate and 500 ml. normal solution of primary alkaline phosphate. By 7-10 days boiling at the reflux-cooler the nucleic acid is cleaved. Then the guanosine precipitate is separated and the adenosine directly isolated from the hydrolytic solution or as a compound of diflicult solubility. Yields: 11.5 g. guanosine and 10.0 g. adenosine.
  • Example 6 100 g. of unrefined nucleic acid with 70-75% pure nucleic acid content are brought to suspension in 200 ml. water, its pH being adjusted to 7.0 with soda-lye, and diluted with l2 liters of a buffering molar alkaline phosphate solution according to McIlvaine, consisting of 165 parts 4 times molar solution sodium phosphate and 35 parts double molar citric acid. By 7-10 days boiling at the reflux-cooler the nucleic acid is cleaved. Then the guanosine precipitate is separated and the adenosine directly isolated from the hydrolytic solution or as a compound of difficult solubility. Yields: 10.5
  • Example 7 7 times molar sodium-acetate solution+7 times molar sodium diethylbarbiturate solution 500 8.5% sodium chloride solution 200 5 times molar hydrochloric acid 600 Water 1400 By 7-10 days boiling at the reflux-cooler the nucleic acid is cleaved. Then the guanosine precipitate is separated and the adenosine directly isolated from the hydrolytic solution or as a compound of difiicult solubility. Yields: 10.4 g. guanosine and 8.5 g. adenosine.
  • nucleosides in which the buffering compound is inorganic.
  • the molar bulfering compound consists of a molar solution containing parts secondary alkaline phosphate and 30 parts primary alkaline phosphate.
  • nucleosides in which the molar buffering compound consists of one part primary alkaline phosphate and two parts secondary alkaline phosphate in a molar solution.
  • nucleosides in which the molar buffering compound consists of 296 ml. normal sodium hydrate and 500 ml. normal primary alkaline phosphate.
  • nucleosides in which the molar buffering compound consists of 623 parts primary calcium phosphate and 377 parts borax.
  • nucleosides in which the molar buflering compound consists of parts 4 times molar sodium phosphate and 35 parts double molar citric acid.
  • nucleosides in which the molar buffering compound is a solution containing sodium citrate and sodalye.
  • nucleosides in which the molar buffering compound is a solution consisting of:

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)

Description

United States Patent METHOD OF PRODUCING NUCLEOSIDES BY CHEMICAL PROCESSING Karl Dimroth, Marburg-Lahn, Kurt Georg V. Holle, Mannheim-Waldhof, Reiner Hamm, Kulmbach, and Lothar Jaenicke, Marburg-Lahn, Germany No Drawing. Application October 16, 1952, Serial No. 315,183
11 Claims. (Cl. 260-2115) This application is a continuation-in-part of our application Serial No. 139,782, filed January 20, 1950, now U. S. Patent 2,698,844.
According to the already known method, the production of nucleosides by hydrolytic cleaving of nucleic acid can be carried through by a 3-4 hours treatment with ammonia at a heat of 175-180 C. In this case a mixture of the purineand pyrimidine-nucleosides is obtained.
The disadvantage of this process consists in realizing a bad yield and in being forced to work with *pressure vessels. If treated under more moderate conditions, e. g. at 115 C., the nucleic acid is only degraded into the mono-nucleotides.
For this reason it was suggested (German Letters Patent No. 693,416) to use volatile organic bases, e. g. pyridine, chinoline etc., a procedure by which the cleaving of nucleic acid will be accomplished in approximately 96 hours. The yield of guanosine and adenosine is considerably higher than that realized by using ammonia; however, pyridine is a very expensive cleavingagent.
It is further known to carry through the cleavage of nucleic acids in an alkaline medium by adding of alkaline earth bases. This procedure has several disadvantages. In this way the adenosine formed by the cleavage of nucleic acid never can be obtained directly.
It was found as a surprise that the hydrolysis of the nucleic acid can also be done without employing the usual inorganic and organic bases if using a neutral aqueous solution at a pH value of 6.5-8, preferably 7- 7.5, this pH value being kept constant by buffering in order to re-rendering inactive the phosphoric acid nascent at the cleaving-process. For bulfen'ng all buffering compounds may be used that are capable to maintain the mentioned pH-value. As well known, buifering compounds are materials, which in an aqueous solution at a given concentration show a determined pH-value and tend to maintain its pH-value even then if acid or basic material is added.
Inorganic or organic buffering compounds may be employed. The phosphoric acid, formed by the hydrolytic cleavage of nucleic acid is buffered and consequently prevented from a further cleavage of the nucleosides formed. Therefore the desired hydrolytic cleaving of the nucleic acid is not specifically due to the cleaving-agent but to means that maintain a determined range of pH.
If pressure-vessels are avoided the hydrolysis can often be carried through considerably faster than it was feasible up to now. Often the solubility-conditions are so favorable that at the cooling-down certain nucleosides as, for instance, guanosine precipitate immediately from the solution and may be obtained in a comparatively pure form. Thus, the nucleoside-yields being equal, this new method constitutes a considerable technical simplification and an essential lowering of costs, as compared with the present method.
The process will now be explained with the aid of the following examples. The invention is in no way limited to the individual measures described in the examples or to the exact sequence of operations, as numerous modifications can be made which will be at once obvious to all skilled in the art.
Example 1 110 g. of unrefined nucleic acid are brought to suspension in 200 ml. of water, its pH being adjusted to 7 with soda-lye, and are diluted'with 10-20 times the quantity of buffer-solution favoring a pH-value of 7 (sodium citrate and soda-lye) which is followed by 9- 10 days boiling at the reflux-cooler. Then the guanosine precipitate is filtered 01f. Yield: 10 g. Hereafter the adenosine is separated directly or as a compound of ditficult solubility.
Example 2 g. of unrefined nucleic acid with 70-75% pure nucleic acid content are brought to suspension in 200 ml. water, its pH being adjusted to 7.0 with soda-lye, and diluted with 1-2 liters of a buffering molar alkaline phosphate solution according to Stirensen, containing 70 parts of secondary alkaline phosphate and 30 parts of primary alkaline phosphate. By 7-l0 days boiling at the reflex-cooler the nucleic acid is cleaved. Then the guanosine precipitate is separated and the adenosine directly isolated from the hydrolytic solution or as a compound of difficult solubility. Yields: 12.2 g. guanosine and 10.5 g. adenosine.
Example 3 100 g. of unrefined nucleic acid with 7075% pure nucleic acid content are brought to suspension in 200 ml. water, its pH being adjusted to 7.0 with soda-lye, and diluted with l-2 liters of a buffering molar alkaline phosphate solution according to Clark and Lubs, consisting of 296 ml. normal solution of sodium hydrate and 500 ml. normal solution of primary alkaline phosphate. By 7-10 days boiling at the reflux-cooler the nucleic acid is cleaved. Then the guanosine precipitate is separated and the adenosine directly isolated from the hydrolytic solution or as a compound of diflicult solubility. Yields: 11.5 g. guanosine and 10.0 g. adenosine.
Example 6 100 g. of unrefined nucleic acid with 70-75% pure nucleic acid content are brought to suspension in 200 ml. water, its pH being adjusted to 7.0 with soda-lye, and diluted with l2 liters of a buffering molar alkaline phosphate solution according to McIlvaine, consisting of 165 parts 4 times molar solution sodium phosphate and 35 parts double molar citric acid. By 7-10 days boiling at the reflux-cooler the nucleic acid is cleaved. Then the guanosine precipitate is separated and the adenosine directly isolated from the hydrolytic solution or as a compound of difficult solubility. Yields: 10.5
g. guanosine and 8.2 g. adenosine.
Example 7 7 times molar sodium-acetate solution+7 times molar sodium diethylbarbiturate solution 500 8.5% sodium chloride solution 200 5 times molar hydrochloric acid 600 Water 1400 By 7-10 days boiling at the reflux-cooler the nucleic acid is cleaved. Then the guanosine precipitate is separated and the adenosine directly isolated from the hydrolytic solution or as a compound of difiicult solubility. Yields: 10.4 g. guanosine and 8.5 g. adenosine.
The invention may be further modified and embodied within the scope of the subjoined claims.
We claim:
1. In a process for the production of nucleosides by hydrolytic cleavage of a nucleic acid by heating the nucleic acid in an aqueous solution the improvements consisting in adjusting the aqueous solution of the nucleic acid to a pH-value of about 6.5 to 7.5 and then heating the same in the presence of 10 to times the amount by weight, calculated on nucleic acid, of a 1 to 7 times molar buffering compound, and herewith maintaining the pH-value at 6.5 to 7.5 by buffering the phosphoric acid split off during hydrolysis.
2. In a process for the production of nucleosides according to claim 1, in which the buffering compound is inorganic.
3. In a process for the production of nucleosides according to claim 1, in which the molar bulfering compound consists of a molar solution containing parts secondary alkaline phosphate and 30 parts primary alkaline phosphate.
4. In a process for the production of nucleosides according to claim 1, in which the molar buffering compound consists of one part primary alkaline phosphate and two parts secondary alkaline phosphate in a molar solution.
5. In a process for the production of nucleosides according to claim 1, in which the molar buffering compound consists of 296 ml. normal sodium hydrate and 500 ml. normal primary alkaline phosphate.
6. In a process for the production of nucleosides according to claim 1, in which the molar buffering compound consists of 623 parts primary calcium phosphate and 377 parts borax.
7. In a process for the production of nucleosides according to claim 1, in which the molar buflering compound consists of parts 4 times molar sodium phosphate and 35 parts double molar citric acid.
8. In a process for the production of nucleosides according to claim 1, in which the molar buffering compound is a solution containing sodium citrate and sodalye.
9. In a process for the production of nucleosides according to claim 1, in which the molar buffering compound is a solution consisting of:
7 times molar sodium-acetate solution+7 times molar sodium diethylbarbiturate solution 500 8.5% sodium chloride solution 200 5 times molar hydrochloric acid 600 Water 1400 References Cited in the file of this patent UNITED STATES PATENTS Phelps Apr. 4, 1939 OTHER REFERENCES Serial No. 257,543, Brederck (A. P. (1.), published 9 April 20, 1943.

Claims (1)

1. IN A PROCESS FOR THE PRODUCTION OF NUCLEOSIDES BY HYDROLYTIC CLEAVAGE OF A NUCLEIC ACID BY HEATING THE NUCLEIS ACID IN AN AQUEOUS SOLUTION THE IMPROVEMENTS CONSISTING IN ADJUSTING THE AQUEOUS SOLUTION OF THE NUCLEIC ACID TO A PH-VALUE OF ABOUT 6.5 TO 7.5 AND THEN HEATING THE SAME IN THE PRESENCE OF 10 TO 20 TIMES THE AMOUNT BY WEIGHT, CALCULATED ON NUCLEIC ACID, OF A 1 TO 7 TIMES MOLAR BUFFERING COMPOUND, AND HEREWITH MAINTAINING THE PH-VALUE AT 6.5 TO 7.5 BY BUFFERING THE PHOSPHORIC ACID SPLIT OFF DURING HYDROLYSIS.
US315183A 1952-10-16 1952-10-16 Method of producing nucleosides by chemical processing Expired - Lifetime US2719844A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US315183A US2719844A (en) 1952-10-16 1952-10-16 Method of producing nucleosides by chemical processing

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US315183A US2719844A (en) 1952-10-16 1952-10-16 Method of producing nucleosides by chemical processing

Publications (1)

Publication Number Publication Date
US2719844A true US2719844A (en) 1955-10-04

Family

ID=23223264

Family Applications (1)

Application Number Title Priority Date Filing Date
US315183A Expired - Lifetime US2719844A (en) 1952-10-16 1952-10-16 Method of producing nucleosides by chemical processing

Country Status (1)

Country Link
US (1) US2719844A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3062808A (en) * 1959-02-18 1962-11-06 Shionogi & Co Process for preparing ribonucleoside-2', 3'-cyclicphosphate
US3176006A (en) * 1963-08-06 1965-03-30 Zahn Rudolf Karl Process for treating desoxyribo-nucleic acid
US3277077A (en) * 1964-06-03 1966-10-04 Merck & Co Inc 3-deoxy ribofuranosyl halides
US3314937A (en) * 1963-07-30 1967-04-18 Vallee Process for producing highly polymerized desoxyribonucleic acids

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2152662A (en) * 1937-12-31 1939-04-04 Francis P Phelps Method for preparing ribose

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2152662A (en) * 1937-12-31 1939-04-04 Francis P Phelps Method for preparing ribose

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3062808A (en) * 1959-02-18 1962-11-06 Shionogi & Co Process for preparing ribonucleoside-2', 3'-cyclicphosphate
US3314937A (en) * 1963-07-30 1967-04-18 Vallee Process for producing highly polymerized desoxyribonucleic acids
US3176006A (en) * 1963-08-06 1965-03-30 Zahn Rudolf Karl Process for treating desoxyribo-nucleic acid
US3277077A (en) * 1964-06-03 1966-10-04 Merck & Co Inc 3-deoxy ribofuranosyl halides

Similar Documents

Publication Publication Date Title
Pontremoli et al. Crystalline D-gluconate 6-phosphate dehydrogenase
US3763009A (en) Synthesis process for the production of ascorbic acid glucoside
US3642772A (en) Process for preparing s-adenosyl homocysteine
DE3440988A1 (en) METHOD FOR CLEAVING PEPTIDES AND PROTEINS ON THE METHIONYL BOND
US2719844A (en) Method of producing nucleosides by chemical processing
Chambers et al. The synthesis of adenosine-5'and uridine-5'phosphoramidates
US2844514A (en) Process for the production of nucleotides
DE1695303A1 (en) Process for the preparation of nucleoside 5'-diphosphates and triphosphates as well as mono- and oligonucleotidyl nucleside-5'-diphosphates and triphosphates
GB1469352A (en) Process for the preparation of sodium percarbonate
Whitby Transglucosidation reactions with flavins
Grimm et al. Synthesis of the “Minor Nucleotide” N6-(γ, γ-Dimethylallyl) adenosine 5'-Phosphate and Relative Rates of Rearrangement of 1-to N6-Dimethylallyl Compounds for Base, Nucleoside, and Nucleotide
US5095115A (en) Preparation of riboflavin 5'-phosphate (fmn) and its sodium salt in a lactone
Briggs et al. The effect of lithium and potassium on the transient state kinetics of the (Ca+ Mg)-ATPase of cardiac sarcoplasmic reticulum.
Plaut et al. A method for the purification of nicotinamide mononucleotide
Schnaitman et al. Localization of oligomycin-sensitive ADP-ATP exchange activity in rat liver mitochondria
GB969419A (en) Process for recovering potassium from brines
US2566123A (en) Stable vitamin b12 solution
Voglmayr et al. A comparison of adenosinetriphosphatase activity in testicular and ejaculated spermatozoa of the ram
JPS5632412A (en) Insulin crystal suspension and its manufacture
Takemura et al. Hydrazinolysis of Nucleic Acids. II. The Formation of Ribo-apyrimidinic Acid from Yeast Ribonucleic Acid
KR880000691B1 (en) Process for preparing water soluble derivatives of cephalexin
US2698844A (en) Production of nucleosides
US3919194A (en) S-substituted 2-thioadenosine-5{40 -monophosphates and process for producing the same
Graham et al. Enzymatic synthesis and reactions of uridine 5′-(5-thio-α-d-glucopyranosyl pyrophosphate)
US2719148A (en) Stabilization of adenosine polyphosphoric acids